Back
Theravance Biopharma Vs. Corcept Therapeutics Industry Stock Comparison
Sell
42
TBPH
Theravance Biopharma
Last Price:
9.46
Seasonality Move:
-14.12%
Buy
74
CORT
Corcept Therapeutics
Last Price:
26.61
Seasonality Move:
8.36%
Sell
42
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.49. The Score for TBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $25.40. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $25.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
TBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 54.8 | Buy |
| Chaikin Money Flow: | -81443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.01 - 9.63) | Buy |
| Bollinger Bands (100): | (8.63 - 10.33) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 60.51 | Buy |
| Chaikin Money Flow: | 772988 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.75 - 24.69) | Buy |
| Bollinger Bands (100): | (21.86 - 27.3) | Buy |
TBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.21 | Buy |
| 20-day SMA: | 9.3 | Buy |
| 50-day SMA: | 9.11 | Buy |
| 200-day SMA: | 9.6 | Sell |
| 8-day EMA: | 9.35 | Buy |
| 20-day EMA: | 9.27 | Buy |
| 50-day EMA: | 9.24 | Buy |
| 200-day EMA: | 9.62 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.25 | Buy |
| 20-day SMA: | 23.47 | Buy |
| 50-day SMA: | 24 | Buy |
| 200-day SMA: | 26.61 | Sell |
| 8-day EMA: | 24.31 | Buy |
| 20-day EMA: | 23.92 | Buy |
| 50-day EMA: | 23.98 | Buy |
| 200-day EMA: | 25.02 | Buy |
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.05 per share.
Theravance Biopharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||